Harrow (HROW) Scheduled to Post Earnings on Wednesday

Harrow (NASDAQ:HROW) is scheduled to release its earnings data after the market closes on Wednesday, November 13th. Analysts expect Harrow to post earnings of ($0.05) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Harrow Stock Down 0.9 %

Shares of HROW stock opened at $52.02 on Tuesday. The stock’s 50-day simple moving average is $47.16 and its 200-day simple moving average is $31.29. The company has a debt-to-equity ratio of 3.18, a quick ratio of 2.43 and a current ratio of 2.60. The firm has a market capitalization of $1.85 billion, a PE ratio of -54.76 and a beta of 0.76. Harrow has a fifty-two week low of $7.60 and a fifty-two week high of $59.23.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on HROW. B. Riley reissued a “buy” rating and issued a $50.00 price objective on shares of Harrow in a report on Thursday, August 29th. Lake Street Capital raised their target price on Harrow from $45.00 to $55.00 and gave the stock a “buy” rating in a report on Friday, October 4th. Finally, Craig Hallum raised their target price on Harrow from $45.00 to $65.00 and gave the stock a “buy” rating in a report on Friday, October 4th.

About Harrow

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.